Search Results for citation:"89 FR 106542"

The National Institute of Mental Health is holding a closed meeting on February 4, 2025, from 3:00 p.m. to 5:00 p.m. to review and evaluate grant applications under the BRAIN Initiative. The meeting will be conducted virtually and is closed to the public to protect personal privacy and confidential information. Rebecca Steiner Garcia is the Scientific Review Officer overseeing this meeting. The meeting is part of the federal mental health research grant program.

The National Institute of General Medical Sciences has announced a closed meeting scheduled for March 27, 2025. This meeting is to review and evaluate grant applications and will take place virtually from 9:30 a.m. to 6:30 p.m. The meeting will be closed to the public to protect trade secrets, commercial property, and personal privacy. Interested individuals can contact Kimberly Hammer for more information.

The National Center for Complementary and Integrative Health (NCCIH) has announced a closed meeting scheduled for February 14, 2025. This meeting is part of a special emphasis panel focused on the feasibility trials for the NIH Music-based Interventions Toolkit for brain disorders of aging, specifically requiring a clinical trial (R34). The meeting will be conducted virtually, and its purpose is to review and evaluate grant applications. The discussion will include sensitive information such as trade secrets or personal data, necessitating the meeting's confidentiality to prevent unwarranted privacy invasions.

The U.S. Department of Health and Human Services (HHS) announced new guidelines for the transplantation of organs from donors with HIV under the HOPE Act. These updated rules state that kidney and liver transplants from HIV-positive donors no longer need to follow specific research criteria if both donor and recipient have HIV. However, transplants involving other organs from HIV-positive donors still require an IRB-approved research protocol. The changes aim to enhance the understanding of organ transplants from HIV-positive donors while ensuring recipient safety and increasing organ access for patients with HIV.